It may be time to pull out your step counters and start adding walking to your daily to-do lists. A recent U.K. study indicates taking 10,000 steps each day can help cut your risk of dementia by half.
Oct 10, 2022
0
121
(HealthDay)—Complete blood cell count parameters at commonly used or optimal thresholds do not offer high accuracy in identifying invasive bacterial infections (IBIs) in febrile infants (≤60 days of age), according to ...
Sep 12, 2017
0
117
Men whose mothers suffered stressful events such as divorce or job loss in early pregnancy are more likely to have fewer and less active sperm, researchers said Thursday.
May 30, 2019
0
61
Working in a physically demanding job, having high blood pressure, and taking multiple medications are among health risks that may undermine a man's fertility, according to a study by researchers at the National Institutes ...
Mar 9, 2015
0
58
Television journalist and host of "Good Morning America" Robin Roberts announced this week that she has myelodysplastic syndrome, or MDS, an uncommon blood and bone marrow disorder.
Jun 15, 2012
1
0
In patients with acute myocardial infarction (heart attack), blood loss from greater use of phlebotomy (blood drawn for diagnostic testing) appears to be independently associated with the development of hospital-acquired ...
Aug 8, 2011
0
0
Scientists from the Cambridge Baker Systems Genomics Initiative have used machine learning to create genetic predictors of blood cell traits, such as white blood cell counts, that are linked to chronic disease.
Jan 12, 2022
0
55
One test of both the power and hunger of any individual or organization is the ability to master any and every new, sufficiently advanced technological opportunity that urgently presents itself to the world at large. For ...
A trio of large-scale genome-wide association studies, or GWAS, have identified more than 15 gene variants responsible for the diversity of white blood cell counts among whites, African-Americans, and Japanese. Supported ...
Jun 30, 2011
0
0
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be ...
May 23, 2011
0
0
